Literature DB >> 1319729

Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities.

H J Guchelaar1, H J Hoekstra, E G de Vries, D R Uges, J W Oosterhuis, H Schraffordt Koops.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1319729      PMCID： PMC1977776          DOI： 10.1038/bjc.1992.188

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  32 in total

1.  Differential heat response of normal and transformed human cells in tissue culture.

Authors:  K Kase; G M Hahn
Journal:  Nature       Date:  1975-05-15       Impact factor: 49.962

2.  Selective lethal effect of supranormal temperatures on mouse sarcoma cells.

Authors:  B C Giovanella; A C Morgan; J S Stehlin; L J Williams
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

3.  Improved tissue perfusion during pressure regulated hyperthermic regional isolated perfusion. A clinical study.

Authors:  W P Fontijne; P H Mook; H S Koops; J Oldhoff; C R Wildevuur
Journal:  Cancer       Date:  1985-04-01       Impact factor: 6.860

4.  The safe use of cisplatin in hyperthermic isolated limb perfusion systems.

Authors:  J M Roseman; D Tench; L R Bryant
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

5.  Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients.

Authors:  A A Forastiere; J F Belliveau; M P Goren; W C Vogel; M R Posner; G P O'Leary
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

6.  Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion.

Authors:  J J Gullo; C L Litterst; P J Maguire; B I Sikic; D F Hoth; P V Woolley
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

7.  Effect of hyperthermia on cisplatin pharmacokinetics in normal dogs.

Authors:  J E Riviere; R L Page; M W Dewhirst; K Tyczkowska; D E Thrall
Journal:  Int J Hyperthermia       Date:  1986 Oct-Dec       Impact factor: 3.914

8.  Temperature dependence of adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity in vitro.

Authors:  T S Herman
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

9.  Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug.

Authors:  K E Wallner; M W DeGregorio; G C Li
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

10.  Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications.

Authors:  J B Vermorken; W J van der Vijgh; I Klein; H E Gall; H M Pinedo
Journal:  Eur J Cancer Clin Oncol       Date:  1982-11
View more
  1 in total

1.  Immunocytochemical analysis of cisplatin-induced platinum-DNA adducts with double-fluorescence video microscopy.

Authors:  C Meijer; E G de Vries; W A Dam; M H Wilkinson; H Hollema; H J Hoekstra; N H Mulder
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.